Sarcoldosis is a chroniconaing graulomatous disease of unknown etiology. An accumulation of CD4+ T cells in the alveolar space ofthe lungs is a characteristic feature of the disease. We have in this study analyzed T-cell receptor (TCR) variable region (V) (6) (7) (8) (9) (10) (11) (12) . Also, in the recognition of so-called superantigens, T lymphocytes bearing particular TCR Vp gene segment products are of critical importance (reviewed in ref. 13).
haplotype. The remainin TCR Va/Vp gene products analyzed in this study-V.12, Vp2, Vp3, Vp5.1, VpS.2/5.3, VpS.39, Vp6.7, Vp8.1, and Vpl2-were in general normlly exprsd by CD4+ T cells, alogh some of them were used to a nfcntoy higher or lower degree by lung T cells compared to peripheral blood T cells. We also performed repeated TCR V gene analyses on some HLA-DR3+ patients and found an assciation between the ratio bronchoalveolar lavage fluid/periperal blood Va2.3+ CD4+ T cells and dinical signs of disease activity. Finally, when analyzing TCR V gene usage by CD8+ bronchoalveolar lavage fluid and peripheral blood T cells, a normal V.2.3 usage was found in all cases, but un-resrtd T-cell e s using other TCR V gene segment products were Identifed.
Sarcoidosis is characterized by the formation ofnoncaseating granulomas, a depressed cell-mediated immunity, and an elevated B-lymphocyte immunoglobulin production. Ninety percent of sarcoidosis patients have involvement of the intrathoracic organs (1) in which CD4+ T cells are accumulated (2) . Lung T cells are accessible for further analysis through the technique of bronchoalveolar lavage (BAL). Such lung compartmentalized CD4+ T cells are implicated in the pathogenesis ofthe disease, since they release interleukin 2 (IL-2), proliferate at a high rate (3) , and express activation markers (4) .
T lymphocytes use a receptor (TCR) to specifically recognize antigen. The variable regions ofthe TCR are constructed through rearrangement of germ-line V (variable), D (diversity), and J (oining) gene segments (5) . A particular TCR Va or Vp gene segment can play a dominant role in the reaction against certain peptide-major histocompatibility complexes (6) (7) (8) (9) (10) (11) (12) . Also, in the recognition of so-called superantigens, T lymphocytes bearing particular TCR Vp gene segment products are of critical importance (reviewed in ref. 13 ).
We have previously described a preliminary correlation between a restricted TCR V gene usage by lung T cells and the HLA haplotype of sarcoidosis patients (14, 15) . In this extended study, we definitively establish an association between usage of TCR V,2.3 by CD4+ T cells accumulated at the site of disease-i.e., in the lungs of sarcoidosis patients-and the HLA-DR3 (17) patients was significantly higher compared to that of DR3-patients (P < 0.001) (Fig. 2) . (Fig. 1B) . In the group of DR3+ healthy controls (n = 6), however, a tendency to use the TCR V,,2.3 gene segment to a higher degree by CD4+ BAL T cells (median, 7.6%; range, 4.2-13.4%) compared to that of CD4+ PBLs (median, 3.8%; range, 2.7-5.1%o) was noted. Indeed, one of the HLA-DR3Y healthy individuals, showing no signs of disease, had a lung restricted TCR Va2.3+ T-cell expansion ( Fig. 1C; no. 4 ). In the HLA-DR3-healthy control subjects (n = 5), no similar tendency of a higher V.2.3 gene usage by lung T cells vs. PBLs was identified (Fig. 1E) . Reactivities with the remaii TCR V-specific mAb showed no signs of abnormal V gene usage (data not shown).
Three healthy control subjects ( (Fig. 3) .
One healthy individual was also analyzed repeatedly; this individual had a V.2.3+ CD4+ BAL T-cell expansion at the second analysis without any obvious signs ofdisease (Fig. 3) in the DR3Y healthy controls the corresponding value was 0.19 x 106 per liter. For the seemingly healthy DR3Y individuals with relative Va2.3+ CD4+ BAL T-cell expansions, one at the first analysis ( Fig. 1C; no. 4) , and the other at a second analysis (Fig. 3) , the absolute numbers of cells were 0.21 x 106 and 0.54 x 106 per liter, respectively. The corresponding average values in the DR3 individuals were 1.09 x 106 per liter of BAL fluid for the patients and 0.18 x 106 per liter of BAL fluid for the healthy controls.
HLA-DR and IL2-R expression by expanded Va2.3+ CD4+ BAL T cells was examined in three DR3Y patients.
HLA-DR was expressed by 57.9%, 80.3%, and 73.2% of the V.2.3+ CD4+ BAL T cells in these patients. The total BAL T-cell populations (CD3+) also expressed HLA-DR to high degrees in two of these patients, 71.3% and 83.3%. In addition, IL-2R was expressed to similar degrees by V,2.3+ CD4+ BAL T cells and CD3+ BAL T-cell populations (2.2%, 7.4%, and 1.3% compared to 6.2% and 3.6%). In sarcoidosis patients, one may hypothesize that a specific antigenic peptide could-in the context of HLA-DR3 (17) and/or -DQ2 molecules-stimulate particularly those CD4+ lung T cells that express Va2.3 to proliferate. Such a preferential stimulation of T cells bearing particular TCR V gene products have been shown in other situations; in T-cell recognition of a tetanus toxin-derived peptide (tt830-844), TCR Vp2.1 was recently shown to be the TCR gene segment of major importance (11) . In sarcoidosis, the origin of such a stimulatory antigenic peptide might be a "foreign sarcoidosis antigen." Alternatively, it may be derived from self antigens, that could show an increased expression in inflammatory situations, such as heat shock proteins (21) .
DISCUSSION
HLA-DR3+ healthy individuals-but not DR3+ control patients-had a slight tendency of preferential relative usage of V,2.3+ by lung CD4+ T cells, although in absolute numbers there were on average 32 times more V,2.3+ CD4+ BAL T cells in the DR3+ sarcoidosis patients compared to the healthy controls. Speculatively, the healthy individuals belonged to the hospital staff and may therefore be overexposed to antigens such as a presumed sarcoidosis antigen. Perhaps 
